Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RoX Health is a Berlin-based digital health innovation studio and venture builder that is a subsidiary of Roche Germany. Founded in 2020, the company acts as a strategic bridge between early-stage digital health startups and the established pharmaceutical ecosystem, focusing on transforming innovative ideas into sustainable healthcare businesses. RoX Health primarily targets unmet needs in neurology, oncology, cardiovascular metabolism, and women's health, providing startups with access to Roche's deep industry expertise, regulatory guidance, and market access networks. The company co-develops and commercializes digital solutions, such as cognitive stimulation therapies for dementia and AI-driven triage platforms, to improve patient outcomes and streamline clinical workflows. By combining the agility of a startup with the resources of a global healthcare leader, RoX Health aims to accelerate the adoption of digital health technologies within the German and international healthcare systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rox.